Clinical Trials · NCT00399893

Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS)

Phase
N/A
Recruitment status
Terminated
Sponsor
Duke University
Enrollment
5
Start date
Dec 2006
Locations
1 site, United States
Primary endpoint
Number of Participants With Decrease in Fasting Total Ghrelin
View Octreotide compound reference